(Q46865596)

25 December 2017

title

N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder (English)

1 reference

25 December 2017

obsessive-compulsive disorder

0 references

1 reference

1 reference

inferred from title

author

Christopher Pittenger

object named as

Christopher Pittenger

2

0 references

John Krystal

8

object named as

John H Krystal

1 reference

25 December 2017

author name string

Daniel L Lafleur

1

1 reference

25 December 2017

Ben Kelmendi

3

1 reference

25 December 2017

Tom Gardner

4

1 reference

25 December 2017

Suzanne Wasylink

5

1 reference

25 December 2017

Robert T Malison

6

1 reference

25 December 2017

Gerard Sanacora

7

1 reference

25 December 2017

Vladimir Coric

9

1 reference

25 December 2017

publication date

22 December 2005

1 reference

25 December 2017

number of pages

3

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

25 December 2017

volume

184

1 reference

25 December 2017

page(s)

254-256

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-005-0246-6

exact match

0 references

cites work

Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse

1 reference

12 December 2020

Symptom stability in adult obsessive-compulsive disorder: data from a naturalistic two-year follow-up study

1 reference

12 December 2020

Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention.

1 reference

12 December 2020

Clinical practice. Obsessive-compulsive disorder

1 reference

12 December 2020

Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial

1 reference

12 December 2020

Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking

1 reference

12 December 2020

Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues

1 reference

12 December 2020

Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder

1 reference

12 December 2020

Riluzole augmentation for treatment-resistant depression

1 reference

12 December 2020

Drug-induced hepatotoxicity

1 reference

12 December 2020

Treatment non-response in OCD: methodological issues and operational definitions

1 reference

12 December 2020

Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study

1 reference

12 December 2020

Neuroscience: deep in thought.

1 reference

12 December 2020

Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls.

1 reference

12 December 2020

Protection against glutamate-induced cytotoxicity in C6 glial cells by thiol antioxidants

1 reference

12 December 2020

Glutamatergic dysfunction in OCD.

1 reference

12 December 2020

Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice.

1 reference

12 December 2020

Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder

1 reference

12 December 2020

Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine

1 reference

12 December 2020

Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress

1 reference

12 December 2020

N-acetyl cysteine-induced blockade of cocaine-induced reinstatement

1 reference

12 December 2020

Electrical stimulation of the anterior limbs of the internal capsules in patients with severe obsessive-compulsive disorder: anecdotal reports.

1 reference

12 December 2020

Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder

1 reference

12 December 2020

Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder

1 reference

12 December 2020

10.1007/S00213-005-0246-6

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

16374600

1 reference

25 December 2017